Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Cagrilintide/semaglutide

A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity

Novo Nordisk · Phase 1 · Recruiting · Enrollment 234

NCT07597018

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Cagrilintide B and Placebo Semaglutide In/rn/rn/rn/r
Cagrilintide D-Injection site 1n/rn/rn/rn/r
Cagrilintide D-Injection site 2n/rn/rn/rn/r
Cagrilintide D-Injection site 3n/rn/rn/rn/r

Not shown

  • Cagrilintide B and Placebo Semaglutide I: endpoint not reported
  • Cagrilintide D-Injection site 1: endpoint not reported
  • Cagrilintide D-Injection site 2: endpoint not reported
  • Cagrilintide D-Injection site 3: endpoint not reported